DEM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.464900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.187500E-02
Normal-vs-Stage2
3.557900E-03
Normal-vs-Stage3
1.034000E-02
Normal-vs-Stage4
1.712830E-01
Stage1-vs-Stage2
3.447600E-01
Stage1-vs-Stage3
6.167200E-01
Stage1-vs-Stage4
3.848600E-01
Stage2-vs-Stage3
1.083240E-01
Stage2-vs-Stage4
4.330400E-01
Stage3-vs-Stage4
1.497240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.383900E-03
Normal-vs-AfricanAmerican
2.356300E-02
Normal-vs-Asian
3.703100E-03
Caucasian-vs-AfricanAmerican
8.722200E-01
Caucasian-vs-Asian
2.558400E-01
AfricanAmerican-vs-Asian
3.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.901100E-03
Normal-vs-Female
3.517200E-03
Male-vs-Female
3.610400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.067800E-02
Normal-vs-Age(41-60Yrs)
5.560800E-03
Normal-vs-Age(61-80Yrs)
6.063200E-03
Normal-vs-Age(81-100Yrs)
6.563600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.274600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.012200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.581400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.191160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.229900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.905200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.784010E-03
Normal-vs-Daily Drinker
6.635400E-04
Normal-vs-Weekly Drinker
2.108100E-02
Normal-vs-Occasional Drinker
1.797840E-03
Normal-vs-Social Drinker
7.279500E-03
Non Drinker-vs-Daily Drinker
7.849600E-01
Non Drinker-vs-Weekly Drinker
2.537600E-01
Non Drinker-vs-Occasional Drinker
5.698400E-02
Non Drinker-vs-Social Drinker
5.720100E-02
Daily Drinker-vs-Weekly Drinker
1.695960E-01
Daily Drinker-vs-Occasional Drinker
2.373800E-02
Daily Drinker-vs-Social Drinker
2.626200E-02
Weekly Drinker-vs-Occasional Drinker
6.535400E-01
Weekly Drinker-vs-Social Drinker
5.724600E-01
Occasional Drinker-vs-Social Drinker
8.239200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.780800E-01
Normal-vs-Grade 2
9.766600E-01
Normal-vs-Grade 3
9.637400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.616200E-02
Grade 1-vs-Grade 3
2.066400E-01
Grade 1-vs-Grade 4
8.780800E-01
Grade 2-vs-Grade 3
7.746000E-01
Grade 2-vs-Grade 4
9.766600E-01
Grade 3-vs-Grade 4
9.637400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.062500E-03
Normal-vs-NonDiabetic
5.235500E-03
Diabetic-vs-NonDiabetic
8.423400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.123600E-02
Normal-vs-NoPancreatitis
4.304000E-03
Pancreatitis-vs-NoPancreatitis
9.291800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.598300E-03
Normal-vs-N1
4.563900E-03
N0-vs-N1
4.237800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.678200E-02
Normal-vs-TP53-NonMutant
3.175800E-02
TP53-Mutant-vs-TP53-NonMutant
5.534600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
